Gradient Capital Advisors, LLC Bristol Myers Squibb CO Transaction History

Gradient Capital Advisors, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Jan 31, 2024	BUY	$48.48 - $57.85 $9,162 - $10,933	189 Added 4.35%	4,534 $232,000
Q3 2023 Oct 24, 2023	SELL	$57.89 - $64.73 $28,250 - $31,588	-488 Reduced 10.1%	4,345 $252,000
Q2 2023 Jul 18, 2023	BUY	$63.71 - $70.74 $2,930 - $3,254	46 Added 0.96%	4,833 $309,000
Q1 2023 Apr 17, 2023	SELL	$65.71 - $74.53 $1,445 - $1,639	-22 Reduced 0.46%	4,787 $331,000
Q4 2022 Feb 03, 2023	SELL	$68.48 - $81.09 $1,643 - $1,946	-24 Reduced 0.5%	4,809 $345,000
Q3 2022 Nov 04, 2022	BUY	$0.13 - $76.84 $628 - $371,367	4,833 New	4,833 $344,000

2,425

1.5B

29.7M

32.2M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $113B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Gradient Capital Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Gradient Capital Advisors, LLC with notifications on news.